SUMMARY The diagnosis of synovial amyloidosis is based upon synovial biopsy. Synovial fluid (SF) in seven patients with amyloid arthropathy associated with chronic renal failure undergoing haemodialysis were studied. The SF and synovial samples of 10 consecutive patients with seronegative mono-or oligoarthritis served as a controls. Six of the seven patients with amyloid positive synovial biopsy specimens showed amyloid in their SF. No amyloid was found in the synovial tissue or fluid of the 10 patients in the control group, the sensitivity being 87-7%. The finding of amyloid in SF was highly reproducible, showing its presence in the same joint on several occasions. The deposits were Congophilia resistant to potassium permanganate pretreatment, and the immunohistochemical analysis proved that they contained P2 microglobulin. The high sensitivity and good reproducibility of the method shows that the finding of amyloid in SF is sufficient for the diagnosis of synovial amyloidosis. It is possible to perform immunohistochemical analysis on the SF sediment. Amyloid arthropathy can therefore be added to the list of conditions in which synovial fluid examination can be clinically helpful.
The diagnosis of synovial amyloidosis is based upon the demonstration of amyloid in synovial tissue. In 1973 Gordon et al showed the presence of amyloid in small fragments of villi in the synovial fluid (SF) in three patients with rheumatoid-like polyarthritis, who were in fact affected by amyloid arthropathy associated with myeloma.2 3 'Since then no new publications have appeared confirming the usefulness of the method. We have studied a group of patients with chronic renal failure and amyloid arthropathy undergoing periodical haemodialysis4 in order to relate SF findings to those of synovial biopsy.
Materials and methods
We have studied the SF in seven patients with chronic renal failure undergoing dialysis (four men, three women; mean age 51 years; range 33-62 years) 
Results
In six of the seven patients with amyloid positive synovial biopsy specimens the SF showed the presence of amyloid (Table 1) . No amyloid was found in the synovial tissue or fluid in the 10 patients in the control group.
In our patients the sensitivity of the study of SF with respect to synovial biopsy specimen was 87-7%. In patient No 6 (amyloid positive in synovial tissue and negative in fluid) the amount of SF was small (2 ml), which might explain the absence of villous fragments; nevertheless, in other patients not included in this series we have found amyloid in similar amounts of SF. There were no statistically significant differences between the findings of the synovial biopsy and those of the SF (McNemar test).
The finding of amyloid in SF proved to be highly reproducible because on examining different samples of SF from the same biopsied joint over long periods of time (average eight months) amyloid was always found to be present ( Table 2 ). The examination of other affected joints in the same patient always showed amyloid in the SF (17 samples from six patients), thus showing that the articular disorder was generalised ( Table 2) .
The amyloid showed a Congophilia resistance to treatment with potassium permanganate in the synovial fluid sediments of all the patients studied, a property apparently shared with AL amyloid (Fig. 1 ) The immunohistochemical analysis confirmed that the amyloid deposits of synovial fluid sediments contained 12 microglobulin. In addition, 12 microglobulin was demonstrated in synovial tissue (knee, wrist, hip) in the three patients in whom it was studied.
Discussion
Gordon et al showed similar findings in amyloid arthropathy associated with myeloma.2 In their study amyloid was found in the synovial tissue of the right wrist in three patients and in the SF of the joints studied (first patient, right wrist and right knee; second patient, left shoulder and both knees; third patient both shoulders). In our cases the amyloid arthropathy was associated with patients with chronic renal failure undergoing haemodialysis. 
